People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered.

by William G. Nelson, MD, PhD

Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.

by Anna Azvolinsky

The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.

by Anna Azvolinsky

Cancer patients in the U.S. are feeling impacts from the new coronavirus.

by Kate Yandell